Cargando…
Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
Hepatitis B virus (HBV) affects approximately 250 million patients worldwide, resulting in the progression to cirrhosis and hepatocellular carcinoma, which are serious public health problems. Although universal vaccination programs exist, they are only prophylactic and not curative. In the HBV life...
Autores principales: | Kim, Sun Woong, Yoon, Jun Sik, Lee, Minjong, Cho, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755466/ https://www.ncbi.nlm.nih.gov/pubmed/34281294 http://dx.doi.org/10.3350/cmh.2021.0093 |
Ejemplares similares
-
Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B
por: Yoo, Jeong-Ju, et al.
Publicado: (2015) -
The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Kim, Minah, et al.
Publicado: (2021) -
Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
por: Chang, Jinhong, et al.
Publicado: (2014) -
Chronic Hepatitis B Infection: New Approaches towards Cure
por: Ogunnaike, Mojisola, et al.
Publicado: (2023) -
Hepatitis B Virus Cure: Targets and Future Therapies
por: Lee, Hye Won, et al.
Publicado: (2020)